A controversial federal program known as “340b” was created to cover the costs for uninsured and vulnerable patients by providing medicine discounts to hospitals, who would then pass the savings on to its patients. However, a new report highlights that the opposite is occurring. Instead of saving money, patients are spending 2.5 times more on medicines at 340b program entities than at non-340b entities. On this episode, we're talking to leading Policy Expert Anthonio Ciaccia [[cha-cha]]to find out why this program with good intentions failed and which Fortune 500 companies are making billions off of this program.
